Literature DB >> 17512190

The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer.

Angela van Baardwijk1, Christophe Dooms, Robert Jan van Suylen, Erik Verbeken, Monique Hochstenbag, Cary Dehing-Oberije, Dennis Rupa, Silvia Pastorekova, Sigrid Stroobants, Ulrich Buell, Philippe Lambin, Johan Vansteenkiste, Dirk De Ruysscher.   

Abstract

The purpose of this study was to investigate the relation between the standardised uptake value (SUV) on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan and hypoxia related markers (HIF-1alpha and CAIX), a proliferation-related marker (Ki-67) and glucose transporters (GLUT-1 and GLUT-3) in non-small cell lung cancer (NSCLC). One hundred and two patients, scheduled for complete resection, received a PET scan in Leuven or Maastricht/Aachen. The maximal SUV (SUV(max)) was correlated with survival and immunohistochemical staining patterns. The actuarial survival was worse for patients showing a high SUV(max), the best discriminative value being 8.0 (Leuven, p=0.032) and 11.0 (Maastricht, p=0.007). Tumours with a high SUV(max) expressed in a higher proportion HIF-1alpha (63.1% versus 37.9%, p=0.024) and GLUT-1 (82.9% versus 62.5%, p=0.025), than tumours with a low SUV(max). No significant difference was found in the expression of CAIX, Ki-67 and GLUT-3. This study supports preclinical data that hypoxia is associated with a higher uptake of FDG.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512190     DOI: 10.1016/j.ejca.2007.03.027

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  62 in total

1.  High maximum standard uptake value (SUVmax) on PET scan is associated with shorter survival in patients with diffuse large B cell lymphoma.

Authors:  Dai Chihara; Yasuhiro Oki; Hiroshi Onoda; Hirofumi Taji; Kazuhito Yamamoto; Tsuneo Tamaki; Yasuo Morishima
Journal:  Int J Hematol       Date:  2011-04-06       Impact factor: 2.490

2.  Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.

Authors:  Hao Zhang; Kristen Wroblewski; Daniel Appelbaum; Yonglin Pu
Journal:  Int J Comput Assist Radiol Surg       Date:  2012-05-30       Impact factor: 2.924

3.  Lymph node density is a prognostic factor in patients with major salivary gland carcinoma.

Authors:  Hidenori Suzuki; Nobuhiro Hanai; Hitoshi Hirakawa; Daisuke Nishikawa; Yasuhisa Hasegawa
Journal:  Oncol Lett       Date:  2015-10-19       Impact factor: 2.967

4.  Prognostic value of fluorine-18 fludeoxyglucose positron emission tomography parameters differs according to primary tumour location in small-cell lung cancer.

Authors:  Tomomi Nobashi; Sho Koyasu; Yuji Nakamoto; Takeshi Kubo; Takayoshi Ishimori; Young H Kim; Akihiko Yoshizawa; Kaori Togashi
Journal:  Br J Radiol       Date:  2016-01-12       Impact factor: 3.039

5.  Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.

Authors:  Shengri Liao; Bill C Penney; Kristen Wroblewski; Hao Zhang; Cassie A Simon; Rony Kampalath; Ming-Chi Shih; Naoko Shimada; Sheng Chen; Ravi Salgia; Daniel E Appelbaum; Kenji Suzuki; Chin-Tu Chen; Yonglin Pu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-09-23       Impact factor: 9.236

6.  In vivo quantification of hypoxic and metabolic status of NSCLC tumors using [18F]HX4 and [18F]FDG-PET/CT imaging.

Authors:  Catharina M L Zegers; Wouter van Elmpt; Bart Reymen; Aniek J G Even; Esther G C Troost; Michel C Ollers; Frank J P Hoebers; Ruud M A Houben; Jonas Eriksson; Albert D Windhorst; Felix M Mottaghy; Dirk De Ruysscher; Philippe Lambin
Journal:  Clin Cancer Res       Date:  2014-10-14       Impact factor: 12.531

7.  FDG PET-CT SUVmax and IASLC/ATS/ERS histologic classification: a new profile of lung adenocarcinoma with prognostic value.

Authors:  Marina Suárez-Piñera; José Belda-Sanchis; Alvaro Taus; Albert Sánchez-Font; Antoni Mestre-Fusco; Marcel Jiménez; Lara Pijuan
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-04-25

8.  Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer.

Authors:  P Veit-Haibach; D De Ruysscher; W van Elmpt; M Das; Martin Hüllner; H Sharifi; K Zegers; B Reymen; P Lambin; J E Wildberger; E G C Troost
Journal:  Radiother Oncol       Date:  2013-09-14       Impact factor: 6.280

Review 9.  18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization.

Authors:  Hossein Jadvar; Abass Alavi; Sanjiv S Gambhir
Journal:  J Nucl Med       Date:  2009-10-16       Impact factor: 10.057

10.  The association of 18F-deoxyglucose (FDG) uptake of PET with polymorphisms in the glucose transporter gene (SLC2A1) and hypoxia-related genes (HIF1A, VEGFA, APEX1) in non-small cell lung cancer. SLC2A1 polymorphisms and FDG-PET in NSCLC patients.

Authors:  Seong-Jang Kim; Sang-Hyun Hwang; In Joo Kim; Min Ki Lee; Chang Hun Lee; Sang-Yull Lee; Eun Yup Lee
Journal:  J Exp Clin Cancer Res       Date:  2010-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.